Klaus Okkenhaug, professor of immunology in the University of Cambridge’s Department of Pathology, told Times Radio that deciding whether or not to give children coronavirus injections was a “difficult question” that requires balancing the benefits over large compared to the direct benefits for children.
It comes after the European Medicines Agency, the EU’s regulator, on Friday approved the Pfizer / BioNTech vaccine for children aged 12 to 15, the first in the bloc to do so.
Germany and Italy have announced plans to vaccinate those under 16, while the United States and Canada have already authorized injections for children aged 12 to 15.
“I think for a whole population it would of course help children get vaccinated because it would also reduce their chances of passing this virus on to their teachers,” said Professor Okkenhaug.
While there is a balance of risks to be struck, he said: “I think given the phenomenal safety records of some of the vaccines, there is a good case for moving forward at least with children. older, say 12 years and older. “